Fig. 8From: Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cellsSchematic diagram of the pathways that lead to the differential responses of HCT116 p53-wild-type and p53-null cells toward oxaliplatinBack to article page